Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where John Killoran is active.

Publication


Featured researches published by John Killoran.


Chemical Communications | 2002

Synthesis of BF2 chelates of tetraarylazadipyrromethenes and evidence for their photodynamic therapeutic behaviour

John Killoran; Lorcan T. Allen; John F. Gallagher; William M. Gallagher; Donal F. O'Shea

The synthesis, spectroscopic characteristics and in vitro cellular uptake properties of a new class of therapeutic window photosensitiser, namely the BF2 chelates of 3,5-diaryl-1H-pyrrol-2-yl-3,5-diarylpyrrol-2-ylidene amines (tetra-arylazadipyrromethenes), are described with the aim of developing a novel class of photodynamic therapeutic agents.


British Journal of Cancer | 2005

A potent nonporphyrin class of photodynamic therapeutic agent: cellular localisation, cytotoxic potential and influence of hypoxia

William M. Gallagher; L. T. Allen; C. O'Shea; Tony J. Kenna; Michael J. Hall; Aoife Gorman; John Killoran; Donal F. O'Shea

We have developed a totally new class of nonporphyrin photodynamic therapeutic agents with a specific focus on two lead candidates azadipyrromethene (ADPM)01 and ADPM06. Confocal laser scanning microscopy imaging showed that these compounds are exclusively localised to the cytosolic compartment, with specific accumulation in the endoplasmic reticulum and to a lesser extent in the mitochondria. Light-induced toxicity assays, carried out over a broad range of human tumour cell lines, displayed EC50 values in the micro-molar range for ADPM01 and nano-molar range for ADPM06, with no discernable activity bias for a specific cell type. Strikingly, the more active agent, ADPM06, even retained significant activity under hypoxic conditions. Both photosensitisers showed low to nondeterminable dark toxicity. Flow cytometric analysis revealed that ADPM01 and ADPM06 were highly effective at inducing apoptosis as a mode of cell death. The photophysical and biological characteristics of these PDT agents suggest that they have potential for the development of new anticancer therapeutics.


New Journal of Chemistry | 2008

A substituted BF2-chelated tetraarylazadipyrromethene as an intrinsic dual chemosensor in the 650–850 nm spectral range

John Killoran; Shane O. McDonnell; John F. Gallagher; Donal O’Shea

The synthesis and spectral analysis of a new class of long wavelength intrinsic fluorosensor is reported. Chemosensor performance reveals large off/on fluorescence intensity responses to acid analyte with low response to microenvironment polarity. Application to ratiometric fluorescence/UV-visible analysis is outlined.


New Journal of Chemistry | 2005

A study of the effects of subunit pre-orientation for diarylpyrrole esters; design of new aryl-heteroaryl fluorescent sensors

John Killoran; John F. Gallagher; Paul V. Murphy; Donal O’Shea

The synthesis, single crystal X-ray structures, spectroscopic properties and molecular mechanics calculations of three systematically substituted 3,5-diaryl-1H-pyrrole-2-carboxylic acid ethyl esters 1a–c are described. The goal is to develop design principles for the generation of new class of fluorescent switches constructed from an aryl-heteroaryl architecture containing a virtual (C0) spacer. The spectroscopic effects of the electron donor p-dimethylamino substituent of 1b and the combined steric and electron donor impact of the o-methyl-p-dimethylamino groups of compound 1c were investigated to determine the required structural motifs to achieve orthogonal pre-orientation of the sensor subunits.


Journal of the American Chemical Society | 2004

In vitro demonstration of the heavy-atom effect for photodynamic therapy

Aoife Gorman; John Killoran; Caroline O'Shea; Tony J. Kenna; William M. Gallagher; Donal F. O'Shea


Journal of Organic Chemistry | 2005

A Modular Synthesis of Unsymmetrical Tetraarylazadipyrromethenes

Michael J. Hall; Shane O. McDonnell; John Killoran; Donal F. O'Shea


Chemical Communications | 2006

Impact of a conformationally restricted receptor on the BF2 chelated azadipyrromethene fluorosensing platform

John Killoran; Donal F. O'Shea


Archive | 2003

Compounds useful as photodynamic therapeutic agents

Donal F. O'Shea; John Killoran; William M. Gallagher


Faculty of Health; Institute of Health and Biomedical Innovation | 2005

A potent nonporphyrin class of photodynamic therapeutic agent: Cellular localisation, cytotoxic potential and influence of hypoxia

William M. Gallagher; L. T. Allen; C. O'Shea; Tony J. Kenna; Michael J. Hall; Aoife Gorman; John Killoran; Donal F. O'Shea


Archive | 2003

Verbindungen die, als photodynamische mitteln, anwendbar sind

William M. Gallagher; John Killoran; Donal F. O'Shea

Collaboration


Dive into the John Killoran's collaboration.

Top Co-Authors

Avatar

Donal F. O'Shea

Royal College of Surgeons in Ireland

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Tony J. Kenna

University of Queensland

View shared research outputs
Top Co-Authors

Avatar

Donal O’Shea

University College Dublin

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Lorcan T. Allen

University College Dublin

View shared research outputs
Top Co-Authors

Avatar

Paul V. Murphy

National University of Ireland

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge